Latest filings (excl ownership)
15-12B
Securities registration termination
22 Dec 20
S-8 POS
Registration of securities for employees (post-effective amendment)
2 Dec 20
S-8 POS
Registration of securities for employees (post-effective amendment)
2 Dec 20
S-8 POS
Registration of securities for employees (post-effective amendment)
2 Dec 20
S-8 POS
Registration of securities for employees (post-effective amendment)
2 Dec 20
RW
Registration withdrawal request
2 Dec 20
8-K
BioSpecifics Announces Completion of Acquisition by Endo Pharmaceuticals
2 Dec 20
SC 14D9/A
Tender offer solicitation (amended)
2 Dec 20
SC TO-T/A
Third party tender offer statement (amended)
2 Dec 20
25-NSE
Exchange delisting
2 Dec 20
SC 14D9/A
Tender offer solicitation (amended)
23 Nov 20
SC TO-T/A
Third party tender offer statement (amended)
18 Nov 20
SC 14D9/A
Tender offer solicitation (amended)
18 Nov 20
10-Q
2020 Q3
Quarterly report
9 Nov 20
8-K
BioSpecifics Reports Third Quarter 2020 Financial and Operating Results
9 Nov 20
SC TO-T/A
Third party tender offer statement (amended)
6 Nov 20
SC 14D9/A
Tender offer solicitation (amended)
6 Nov 20
SC 14D9
Tender offer solicitation
2 Nov 20
SC TO-T
Third party tender offer statement
2 Nov 20
SC TO-C
Information about tender offer
19 Oct 20
8-A12B/A
Registration of securities on exchange (amended)
19 Oct 20
SC14D9C
Written communication relating to third party tender offer
19 Oct 20
8-K
BioSpecifics to be Acquired by Endo Pharmaceuticals
19 Oct 20
SC TO-C
Information about tender offer
19 Oct 20
8-K
Regulation FD Disclosure
14 Sep 20
424B5
Prospectus supplement for primary offering
31 Aug 20
8-K
Entry into a Material Definitive Agreement
31 Aug 20
8-K
Regulation FD Disclosure
11 Aug 20
10-Q
2020 Q2
Quarterly report
10 Aug 20
8-K
BioSpecifics Reports Second Quarter 2020 Financial and Operating Results
10 Aug 20
8-K
BioSpecifics Appoints Alex Monteith as Chief Business Officer
20 Jul 20
EFFECT
Notice of effectiveness
20 Jul 20
S-3/A
Shelf registration (amended)
15 Jul 20
CORRESP
Correspondence with SEC
15 Jul 20
8-K
Regulation FD Disclosure
14 Jul 20
UPLOAD
Letter from SEC
30 Jun 20
S-3
Shelf registration
26 Jun 20
8-K
Amendments to Articles of Incorporation or Bylaws
15 Jun 20
8-K
Regulation FD Disclosure
12 Jun 20
8-K
Departure of Directors or Certain Officers
8 Jun 20
Latest ownership filings
SC 13G/A
RICE HALL JAMES & ASSOCIATES, LLC
16 Feb 21
SC 13G/A
RENAISSANCE TECHNOLOGIES LLC
10 Feb 21
4
Change in insider ownership
8 Dec 20
SC 13D/A
Endo International plc
4 Dec 20
4
Jennifer M Chao
2 Dec 20
4
Toby Wegman
2 Dec 20
4
Corey N. Fishman
2 Dec 20
4
Mark N Wegman
2 Dec 20
4
Michael Schamroth
2 Dec 20
4
Joseph Truitt
2 Dec 20
4
Paul Gitman
2 Dec 20
4
PATRICK HUTCHISON
2 Dec 20
4
Michael A. Sherman
2 Dec 20
SC 13D/A
Wegman Toby
2 Dec 20
SC 13D
Wegman Toby
30 Oct 20
3
Initial statement of insider ownership
29 Oct 20
SC 13D
Endo International plc
29 Oct 20
4/A
Joseph Truitt
19 Oct 20
4
Paul Gitman
17 Jul 20
4
Toby Wegman
17 Jul 20
4
Jennifer M Chao
17 Jul 20
4
Mark N Wegman
17 Jul 20
4
Michael Schamroth
17 Jul 20
4
Joseph Truitt
29 May 20
4
Corey N. Fishman
4 May 20
4
Michael A. Sherman
4 May 20
4
Corey N. Fishman
15 Apr 20
4
Michael A. Sherman
15 Apr 20
3
Michael A. Sherman
15 Apr 20
3
Joseph Truitt
15 Apr 20
3
Corey N. Fishman
15 Apr 20
4
Jennifer M Chao
17 Mar 20
SC 13G/A
Beneficial ownership report (amended)
13 Feb 20
SC 13G
Beneficial ownership report
11 Feb 20
SC 13G/A
Biospecifics Technologies Corp
11 Feb 20
SC 13G/A
Biospecifics Technologies Corp
5 Feb 20
4
PATRICK HUTCHISON
10 Jan 20
3
PATRICK HUTCHISON
10 Jan 20
4
PATRICK M CALDWELL
22 Nov 19
4
J KEVIN BUCHI
25 Oct 19